US Supreme Court In Favour Of Teva In Multiple Sclerosis Drug Case

Teva Pharmaceuticals won a case in its fight with generic drugmakers over patent protections for Copaxone, its best-selling multiple sclerosis drug. An earlier appeals court ruling had invalidated the patent, which is due to expire in September 2015, but in the latest ruling, the justices said that the U.S. Court of Appeals for the Federal Circuit had taken an incorrect approach in analysing whether the patent was valid or not.

http://ift.tt/1JzmhdS